GRCL

Gracell Biotechnologies Inc. American Depositary Shares

Delisted

GRCL was delisted on the 21st of February, 2024.

33 hedge funds and large institutions have $72.9M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 4 closing their positions.

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
11
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Temasek Holdings
1
Temasek Holdings
Singapore
$31.9M 9,901,940
CII
2
Capital International Inc
California
$9.71M 3,016,371 +22,676 +0.8%
FLSM
3
Frazier Life Sciences Management
California
$9.31M 2,890,102 -221,449 -7%
EC
4
EcoR1 Capital
California
$6.19M 1,921,310
Federated Hermes
5
Federated Hermes
Pennsylvania
$4.18M 1,298,578
VC
6
Vivo Capital
California
$3.1M 961,359
BlackRock
7
BlackRock
New York
$3.08M 954,858 -54,290 -5%
GPP
8
Great Point Partners
Connecticut
$1.45M 449,049 +449,049 New
CIS
9
Capital International Sarl
California
$981K 304,582 +2,400 +0.8%
SSA
10
Schonfeld Strategic Advisors
New York
$870K 270,173 +12,249 +5%
Morgan Stanley
11
Morgan Stanley
New York
$705K 219,108 -329,927 -60%
Ensign Peak Advisors
12
Ensign Peak Advisors
Utah
$324K 100,741
Invesco
13
Invesco
Georgia
$302K 93,907 +352 +0.4%
Renaissance Technologies
14
Renaissance Technologies
New York
$162K 50,300 +400 +0.8%
Barclays
15
Barclays
United Kingdom
$125K 38,730 -1,700 -4%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$106K 33,164
Bank of America
17
Bank of America
North Carolina
$97K 30,241 -28,219 -48%
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$79K 24,646 +24,646 New
Goldman Sachs
19
Goldman Sachs
New York
$75K 23,319 -959 -4%
VIA
20
Vident Investment Advisory
Georgia
$54K 16,681 -3,280 -16%
CC
21
Cannell Capital
Wyoming
$46K 14,299 +12,110 +553%
TRCT
22
Tower Research Capital (TRC)
New York
$27K 8,357 +7,751 +1,279%
O
23
OrbiMed
New York
$25.4K 7,884,870
Wells Fargo
24
Wells Fargo
California
$15K 4,630 -510 -10%
UBS Group
25
UBS Group
Switzerland
$13K 3,903 +3,903 New